Original NEXUS Contract - Laserfiche WebLink

Home Browse Search

establishing measurement and accountability systems for documenting outcomes, such as increased performance improvements and best or promising practices. 9. Collaborate on components to ensure the provision of appropriate and effective technical assistance services. 10. Collaborate to compile and publish accomplishments, best practices, and lessons learned during the project period (e.g., through conferences, guidance, material development, webinars, data sharing publications, other social media, participation in meetings, committees, conference calls and working groups related to the cooperative agreement and its projects Program Income: Any program income generated under this grant or cooperative agreement will be used in accordance with the Addition alternative. Addition alternative: Under this alternative, program income is added to the funds committed to the project/program and is used to further eligible project/program objectives. Note: The disposition of program income must have written prior approval from the GMO. FUNDING RESTRICTIONS AND LIMITATIONS Notice of Funding Opportunity (NOFO) Restrictions: Restrictions that must be considered while planning the programs and writing the budget are: •Recipients may not use funds for research. @Recipients may not use funds for clinical care except as allowed by law. •Recipients may use funds only for reasonable program purposes, including personnel, travel, supplies, and services. *Generally, recipients may not use funds to purchase furniture or equipment. Any such proposed spending must be clearly identified in the budget. ■Reimbursement of pre -award costs generally is not allowed, unless the CDC provides written approval to the recipient. e0ther than for normal and recognized executive -legislative relationships, no funds may be used for: o publicity or propaganda purposes, for the preparation, distribution, or use of any material designed to support or defeat the enactment of legislation before any legislative body o the salary or expenses of any cooperative agreement or contract recipient, or agent acting for such recipient, related to any activity designed to influence the enactment of legislation, appropriations, regulation, administrative action, or Executive order proposed or pending before any legislative body. a See Additional Requirement [AR) 12 hgW/Iwww.cdc.ov/grants/add it ion aIrequiremenWindex.htmWar 12) for detailed guidance on this prohibition and additional_ guidance_ on lobbying ror CDC recipients (littp://www.cdc.,eov/gran(sfdocuments/Anti- Lobbying_Restrictions_ for _ CDC _Grantees July 2012.pdf). a The direct and primary recipient in a cooperative agreement program must perform a substantial role in -carrying out project outcomes and not merely serve as a conduit for an award to another party or provider who is ineli ible_ a In accordance with the United States Protecting Life in Global Health Assistance policy, all non-governmental organization (NGO) applicants acknowledge that foreign NGOs that receive funds provided through this award, either as a prime recipient or subrecipient, are strictly prohibited, regardless of the source of funds, from performing abortions as a method of family planning or engaging in any activity that promotes abortion as a method of family planning, or to provide financial support to any other foreign non-governmental organization that conducts such activities. See Additional Requirement (AR) 35 for applicability (https://www.cdc.gov/grants/additiona[requirements/ar-35.htm1). Per the Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, 2019 (P.L. 115-245), funds may not be used to purchase syringes or other equipment use solely in the drug injection process. Any SSP receiving technical assistance or engaged in any projects under this NOFO must be located in a jurisdiction that has a Determination of Need concurrence from CDC (see ht1ps:1/www.cdc.govlliiylrisklssps- jurisdictions.html) See HHS guidance on use of federal funds for syringe services programs at Page 2 of 4